Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003345 |
---|---|
Receipt number | R000004057 |
Scientific Title | Weekly bortezomib + dexamethasone therapy for elderly patients with relapsed or refractory multiple myeloma (A multicenter clinical phase II trial, JMSG-0902) |
Date of disclosure of the study information | 2010/03/17 |
Last modified on | 2015/10/02 08:45:32 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/03/17 10:15:16 | ||
2 | Update | 2010/03/17 19:23:42 | Public title Public title Acronym Acronym |
|
3 | Update | 2010/03/17 19:24:42 | Trial characteristics_1 Trial characteristics_2 Developmental phase |
|
4 | Update | 2010/03/17 20:36:45 | Interventions/Control_1 Interventions/Control_1 Key inclusion criteria Key inclusion criteria Key exclusion criteria Key exclusion criteria |
|
5 | Update | 2010/03/17 20:41:01 | Key inclusion criteria |
|
6 | Update | 2010/03/17 20:42:56 | Public title |
|
7 | Update | 2010/06/04 18:11:01 | Recruitment status |
|
8 | Update | 2010/10/18 17:32:44 | Email |
|
9 | Update | 2011/04/19 17:04:48 | Organization Organization Division name Division name Address Address |
|
10 | Update | 2011/09/22 13:35:17 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
11 | Update | 2012/03/19 16:23:38 | ||
12 | Update | 2012/07/03 16:44:03 | Key inclusion criteria Key inclusion criteria |
|
13 | Update | 2014/03/18 20:00:48 | Recruitment status Last follow-up date |
|
14 | Update | 2015/10/02 08:45:32 | Recruitment status Publication of results |